The Impact of Phosphate Metabolism on Healthy Aging

Recruiting now · Early Phase 1

Conditions studied: Hypophosphatemia, Rickets, Hypercalciuria, XLH, HHRH

In brief

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).

Key facts

Study ID
NCT03771105
Run by
Yale University
People needed
30
Starts
2019-01-01
Expected to finish
2028-04-01
Last updated by the study team
2026-05-27

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.